ABBVD
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 · BCBA:ABBVD
30.88 USD0.4600 +1.51%
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 (BCBA:ABBVD) last traded at 30.88 USD, up 1.51% on the day. Over the past year the stock is up 36.52%. Its 52-week range is 20.13 to 31.48. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open31.48
Day range30.88 – 31.48
52-week range20.13 – 31.48
Volume26
Average volume (10 days)262
Market cap521.11 B
P/E5.58
EPS (TTM)5.53
Dividend yield1.32%
Beta (1 year)−0.0778
Revenue (TTM)62.35 B
Employees57.00 K
Performance
+2.08%1 week
+12.09%1 month
+16.05%3 months
+43.96%6 months
+30.08%Year to date
+36.52%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Weekly Recap: Q3 financial gains and Skyrizi Crohn’s FDA approvalTradingView · 02 Nov 2026
- The top 5 analyst questions from AbbVie’s Q3 earnings callStock Story · 01 Nov 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Key facts: AbbVie, Inc. Q3 revenue $17.404B; Skyrizi approved; lutikizumab successTradingView · 31 Oct 2026
- ABBV Q3 deep dive: Immunology and neuroscience drive growth, pipeline progress continuesStock Story · 31 Oct 2026
- AbbVie Inc. Stock 12‑Month Price Target Raised to $291TradingView · 30 Oct 2026
- LLY, ABBV Stocks Hit All-Time High – Here’s What’s Driving Investor Enthusiasm TodayStocktwits · 30 Oct 2026
- AbbVie Stocks Rise 1.75% With Two Medicines Providing Nearly Half of RevenueGuruFocus · 30 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.